California Institute for regenerative medicine
The State stem cell agency
University of California, San Francisco
Awards as PI
Understanding hESC-based Hematopoiesis for Therapeutic Benefit
Stem Cells Dev 2009
Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures.
Clin Transl Sci 2011
Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease.